ARTICLE | Clinical News
MabThera rituximab regulatory update
October 4, 2010 7:00 AM UTC
CHMP issued a positive opinion to extend the indication of MabThera rituximab from Roche to include the treatment of follicular lymphoma in patients responding to induction therapy. CHMP is part of th...